@sabrinainvests: AI stock meets biotech stock.. Avalon Globocare sounds about right. With an increased valuation of the global clinical laboratory service market, aquisition of a leading clinic diagnostics company and rights to the first AI enhanced protein breathalyzer, the company is on the right track to see upside potential in early 2023. #stockstobuy #stockwatchlist #stocks #biotechstocks #greenscreen ***this is a sponsored video